en English is Íslenska

Article

University of Iceland > Heilbrigðisvísindasvið > Rit starfsmanna >

Please use this identifier to cite or link to this item: https://hdl.handle.net/1946/20708

Title: 
  • Loss of heterozygosity at chromosome 11 in breast cancer: Association of prognostic factors with genetic alterations
Keywords: 
Published: 
  • September 1995
Abstract: 
  • We examined DNA from 116 female and four male breast cancer patients for loss of heterozygosity (LOH). DNA was analysed by polymerase chain reaction using ten microsatellite markers on chromosome 11. Three distinct regions of LOH were identified: 11p15.5, 11q13 and 11q22-qter with a LOH frequency of 19, 23 and 37-43% respectively. The marker D11S969 showing the highest frequency of LOH (43%) is located at the 11q24.1-q25 region. No previous molecular genetic studies have shown frequent LOH at the region telomeric to q23 on chromosome 11. Southern analysis revealed that LOH at 11q13 was due to amplification, whereas LOH at 11q22-qter was due to deletion. LOH at 11p15.5 was associated with paucity of hormone receptor proteins, high S-phase and positive node status. An association was found between LOH at 11q13 and positive node status. LOH at the 11q22-qter region correlated with a high S-phase fraction. A significant association was found between LOH at 11p15 and chromosome regions 17q21 (the BRCA1 region) and 3p.

Sponsor: 
  • Nordic Council of Ministers, University of Iceland Graduate Research Fund, the Nordic Cancer Union, the Icelandic Cancer Society, the Memorial Fund of Bergthora Magnusdottir and Jakob B Bjarnason, the Science Fund of Iceland and the Science Fund of the University Hospital of Iceland.
Citation: 
  • British Journal of Cancer, 1995, 72, 696-701
ISSN: 
  • 0007-0920
Accepted: 
  • Mar 24, 2015
URI: 
  • http://hdl.handle.net/1946/20708


Files in This Item:
Filename Size VisibilityDescriptionFormat 
Gudmundsson1995BrJCan.pdf1,19 MBOpenHeildartextiPDFView/Open